TRIM21 and interstitial lung disease: In our study, one patient with Ro52 + and NXP2 + developed symmetric muscle weakness in the lower limbs and another patient with Ro52 + and cN1 + developed respiratory failure, ILD, Raynaud’s phenomenon, myalgia, and arthralgia.